SEC asking U.S. drugmaker Pfizer for data on Bextra, Celebrex

NEW YORK (AP) - Pfizer Inc. is responding to a request from the U.S. Securities and Exchange Commission for information and documents on its Bextra and Celebrex painkillers, the drugmaker said Tuesday in a filing....More